英文名称:Gliclazide Modified Release Tablets 适应症:当单用饮食疗法,运动治疗和减轻体重不足以控制血糖水平的成人非胰岛素依赖型糖尿病(2 型)。 主要成分:本品主要成份格列齐特缓释片。 规格:60mg 相互作用:1.以下药品可能会增加低血糖的危险,禁止联合应用:咪康唑(全身途径,口服凝胶):增加降糖作用并可能会出现低...
The large, real world, observational, and international EASYDia trial evaluated the effectiveness of gliclazide modified release (MR) 60mg in individuals with type 2 diabetes with a broad range of diabetes history, body mass index (BMI) and background antihyperglycemic treatment. A total of 7170 ...
Evaluation of the pharmaceutical quality of modified-release tablets containing 60 mg gliclazide, applied in the therapy of diabetes mellitus type 2. AIMS: To study the relationship between the pharmacokinetics (PK) of gliclazide and its long-term pharmacodynamic (PD) effect in a large population of...
GLICLAZIDE 60 MG MR TABLETS (Leaflet) Scheme Rec.INN ATC (Anatomical Therapeutic Chemical Classification) A10BB09 CAS registry number (Chemical Abstracts Service) 0021187-98-4 Chemical Formula C15-H21-N3-O3-S Molecular Weight 323 Therapeutic Category ...
欧盟HMA上市药品数据库提供Gliclazide 60mg Prolonged Release Tablets药品的基本信息,包括通用名gliclazide,中文名格列齐特,ATC代码A10BB09 gliclazide以及上市许可持有人FOCUS PHARMACEUTICALS LIMITED UNIT 5 FARADAY COURT BURTON UPON TRENT STAFFORDSHIRE DE14 2WX UN
Gliclazide Modified Release Tablets English name: Gliclazide Sustained-release Tablets Chinese pinyin: Gelieqite Huanshi Pian 【Approval number】SFDA approval number H20063861 【Indications】Adult type 2 diabetes when diet alone, exercise therapy and weight loss are not enough to control blood sugar level...
The observation of treatment of Gliclazide Modified Release Tablet in Type 2 diabetic patients 目的:探讨格列齐特缓释片治疗2型糖尿病患者后血糖、糖化血红蛋白及C肽(C-P)等指标的变化.方法:2005年2月～2006年12月在我院门诊及住院的2型糖尿病患者78例,随机分为两... 李蕾,张永红,薛元明 - 《中国医药...
The recommended dose for T2DM of gliclazide ranges from 40 mg to 320 mg daily. Currently, gliclazide tablets are available in the market in conventional immediate release or modified release dosage form to maintain normal plasma glucose levels. Single oral dose gliclazide shows, poor aqueous ...
1.Clinical observation of type 2 diabetes treatment by use of gliclazide modified release tablets instead of Gliclazide Ordinary Tablets格列齐特普通片改为格列齐特缓释片治疗2型糠尿病的临床观察 2.Study on the Formulation and Quality of Gliclazide Sustained Release Tablet;格列齐特缓释片处方筛选及质量研...
The model was used to predict the HPMC K4M content in modified-release gliclazide 30 mg and extended-release quetiapine 200 mg tablets. Keywords鈥擧ypromellose, gliclazide, drug release, modifiedrelease tablet, mathematical model.Farzad Khajavi...